Stay updated on Fostamatinib in wAIHA Clinical Trial
Sign up to get notified when there's something new on the Fostamatinib in wAIHA Clinical Trial page.

Latest updates to the Fostamatinib in wAIHA Clinical Trial page
- Check7 days agoChange DetectedThe record presents a completed Phase 3 trial of fostamatinib for warm antibody autoimmune hemolytic anemia, including its eligibility criteria, study locations, treatment arms, and outcome measures.SummaryDifference85%

- Check14 days agoChange DetectedThe site revision label changes from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check21 days agoChange DetectedAn NIH notice about updates to its websites and terminology appears above the 403 error page.SummaryDifference1%

- Check28 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check35 days agoChange DetectedThe site footer revision changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check55 days agoChange DetectedThe study record page now shows a 403 Forbidden error, blocking access to the content and preventing the study details from loading.SummaryDifference17%

Stay in the know with updates to Fostamatinib in wAIHA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fostamatinib in wAIHA Clinical Trial page.